Frontlight ResearchEarly access
Idiopathic pulmonary fibrosis trials in China
6 of 26 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleInspiratory Flow Rate Capability in Pulmonary Fibrosis Patients
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 60
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07820254 - No phaseTaking peopleA Prospective, Multi-Center Registry Study of Progressive Pulmonary Fibrosis (PPF) in China (PROFINA)
- Where
- Beijing
- People
- 600
- Run by
- Zuojun Xu
See details and how to joinNCT07683728 - No phaseNot yet taking people in ChinaDisease-syndrome Characteristics of IPF
- Where
- Zhengzhou
- Age
- 18 years and over
- People
- 2,864
- Run by
- Henan University of Traditional Chinese Medicine
See details and how to joinNCT07178392 - No phaseNot yet taking people in ChinaIdiopathic Pulmonary Fibrosis Cohort of TCM
- Where
- Zhengzhou
- Age
- 40 years and over
- People
- 1,000
- Run by
- Henan University of Traditional Chinese Medicine
See details and how to joinNCT07162870 - No phaseNot yet taking people in ChinaPerioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 250
- Run by
- Zhejiang University
See details and how to joinNCT06922916 - No phaseTaking peopleA Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
- Where
- Jinan
- Age
- 18 years to 80 years
- People
- 610
- Run by
- Qianfoshan Hospital
See details and how to joinNCT05895409